Publications by authors named "S D Telang"
Introduction: Patients who have poorly controlled diabetes mellitus are at increased risk of periprosthetic joint infection (PJI). Nevertheless, an optimal preoperative hemoglobin A1c (HbA1c) threshold has not been established. This study sought to identify preoperative HbA1c thresholds that were predictive of adverse outcomes for total hip (THA) and total knee arthroplasty (TKA) patients.
View Article and Find Full Text PDFArticle Synopsis
- There is currently no universal guideline on how much activity patients should restrict themselves to after total hip arthroplasty (THA), which is the surgery to replace a hip joint.
- A systematic review analyzed various studies to see if allowing more activity post-surgery affects outcomes like implant survivorship, patient satisfaction, and ability to return to sports.
- Results indicated that patients who were more active post-THA generally had similar or better results regarding implant longevity, and there was a positive relationship between higher activity levels and improved mental health and satisfaction, although more detailed studies are needed for concrete guidelines.
Article Synopsis
- This study examines whether giving tranexamic acid (TXA) to total joint arthroplasty (TJA) patients receiving apixaban can lower the risk of postoperative bleeding without increasing thromboembolic events.
- Researchers analyzed data from over 118,000 TJA patients and found that those who received both apixaban and TXA had significantly lower rates of bleeding complications and transfusions compared to those who only received apixaban.
- The findings suggest that using TXA in conjunction with apixaban during surgery is beneficial for reducing bleeding risks without raising the chances of serious blood clots or heart problems, making it a recommended practice for surgeons.
Background: Retrospective data supporting the use of tranexamic acid (TXA) among high-risk total joint arthroplasty (TJA) patients are limited by surgeon selection bias. This study sought to evaluate the thromboembolic risk associated with TXA administration among elective arthroplasty patients who have history of venous thromboembolism while accounting for surgeon selection.
Methods: A healthcare database was retrospectively queried from 2015 to 2021 to identify all patients who had a history of deep vein thrombosis or pulmonary embolism who underwent elective TJA.
Background: Venous thromboembolism (VTE) and dislocation are well-described complications following total hip arthroplasty (THA). However, the relationship between THA dislocation and venous thromboembolism remains unclear. This study sought to determine the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who experience a hip dislocation and subsequent closed reduction following primary THA.
View Article and Find Full Text PDF